now browsing by category
Cryptocurrency has a good chance of taking over the banking industry and its stock has been bought by many enthusiastic investors. Paul Mampilly, a stock market expert has an interest in digital currency and says that he believes in Bitcoin, but in his investment newsletters he’s telling people they should refrain from buying Bitcoin right now. Why is that? When an asset like Bitcoin becomes too popular, that demand drives prices artificially high and a bubble forms just as it did back in 2000 with the dot-com crash and the 2008 mortgage crisis. Mampilly says there’s already signs that Bitcoin has reached its high and that it’s going to have a steady downward track that’s going to make it too risky to invest in.
Paul Mampilly shares his investment information through an independent information news organization known as Banyan Hill Publishing, and he writes both articles and email newsletters through their platform. He previously made millions as an advisor to high net worth clients in investment banking and as a portfolio director at one of Wall Street’s top hedge funds. He had immigrated to the US over 20 years ago to study accounting and finance at Montclair State University, and he later completed his master’s at Fordham University. Mampilly started out researching credit and alternative investments at Deutsche Bank, and then moved up to more prominent positions at ING and Banker’s Trust. The hedge fund Mampilly joined in 2006 was Kinetics International Fund, and it was praised by Barron’s for Mampilly’s work in raising $25 billion in client assets, and making investments that yielded over 20% in returns.
Outside of the offices of the banks and investment firms, Paul Mampilly has also spoken to several media outlets like CNBC and Fox Business, and he was quoted as predicting the recession about a year prior to it happening. He also was one of the first investors to predict the success of Facebook and the takeoff of Sarepta Therapeutics. Even during the recession, Mampilly made an investment that turned $50 million into $88 million and helped him win an investment competition that the Templeton Foundation hosted. By 2016, Paul Mampilly had grown tired of always working away from home and retired at the early age of 42. He didn’t quit investing though, and he’s used his newsletters starting with “Profits Unlimited” to help people in more ways than he ever did on Wall Street. So far, Mampilly’s newsletters have gained over 60,000 followers.
Visit Paul Mampilly’s Facebook page @ https://www.facebook.com/PaulMampillyGuru/
When Luiz Carlos Trabuco Cappi assumed Bradesco’s presidency in 2009, the bank had lost its lead to Itau Unibanco. After assuming the office, he ruled out being in the chase for leadership claiming that leadership in the industry is not a goal. He categorically stated that their major goal was to serve the municipalities excellently.
Luiz Carlos Trabuco Cappi has over 40 years of experience working for the company, and this made him the best match for the position. His knowledge, experience, and familiarity with the firms’ operations, Luiz Carlos Trabuco Cappi was appointed to head the company. The company prioritizes continuity and renewal, and thus, Luiz Carlos Trabuco Cappi was the best suited for that position.
Luiz Carlos Trabuco Cappi’s Achievements
In 2015, Luiz Carlos Trabuco Cappi took a bold step that brought Bradesco Bank back to the leadership position. After being approved by Lazaro Brandao, the chairman of the board, he bought HSBC at the cost of $5.2 billion. The acquisition saw the bank assume the first position in the private segment. The deal made Bradesco outperform Itau Unibanco in three critical categories namely total investment funds, the number of account holders and branch network. At the same time, Bradesco bet their biggest rival in the sector in loans granted, deposits and assets.
Speaking to MONEY at the time of the acquisition, Luiz Carlos Trabuco Cappi stated that without the deal the firm would strive through a six year period of organic growth to achieve what it had achieved with HSBC acquisition. For that reason, Luiz Carlos Trabuco Cappi was named the Entrepreneur of The Year by DINHEIRO.
Luiz Carlos Trabuco Cappi will go down in history as the fourth president of the bank. A position that had been held by Amador Aguiar, the founder of the organization, Lazaro Brandao, current chairman of the board, and Cypriano, who left the institution in 2009.
Luiz Carlos Trabuco Cappi was born in Marilia in 1951. He graduated from the University of Sao Paulo with an undergraduate bachelor degree in philosophy, science, and letters. Luiz Carlos Trabuco Cappi career in the banking sector began in 1969 when he joined Bradesco Bank. The hardworking and visionary leader grew up the hierarchy levels holding several managerial positions. In 2009 he was elevated to serve as the president of the bank. This was after his remarkable performance while he served at Bradesco Seguros from 2003 to 2009. His work at Bradesco Seguros was significant as it earns Bradesco 30 percent of the organization’s profit to date.
After assuming the presidency, Luiz Carlos Trabuco Cappi created a corporate university, which began to renew leadership cadres. With this university, Bradesco found it easy to search for professionals in the banking sector. In 2015, Luiz Carlos Trabuco Cappi surprised many when he turned down an opportunity from President Dilma Rousseff to serve as the ministry of finance. Sources within the company indicate that he is the most suited candidate to succeed Lazaro Brandao, the chairman of the council. According to sources from his inner circle, Luiz Carlos Trabuco Cappi stated that his DNA is in Bradesco.
The visionary leader is always optimistic about the future of the industry. Luiz Carlos Trabuco Cappi states that the insurance sector is an extension of the state as it is essential for the maintenance of social welfare. He further argues that the current problems in the Brazilian banking sector are critical in defining the future. He further urges the government to understand the role of insurance in the modern society to help the industry evolve.
Amicus Therapeutic is a biopharmaceutical company. This organization was founded in 2002 and it works to combat orphan and rare diseases. Amicus was founded by different venture capital firms who combined their resources. These firms include Radius Ventures, Canaan Partners and New Enterprise Associates. The company is led by three key people which include CEO John Crowley, COO Bradley Campbell and the company’s Chief Financial Officer, Willian Baird.
Amicus Therapeutics is a leading research and treatment facility in the fight against rare diseases. An orphan disease is a condition that is experienced by 200,000 people or fewer within a large population of people. A rare disease is defined by its ability to affect a small percentage of a population. Most rare diseases are genetic and the same is also true for orphan diseases.
The founders of Amicus realize that rare diseases can still negatively impact various ethnic groups and populations from around the world. Diseases such as cystic fibrosis, Lou Gehrig’s disease, Hamburger disease and Tourette’s syndrome falls into the rare and orphan diseases categories. Other diseases such as gigantism and job syndrome are also treated by this medical organization.
Various pharmaceutical treatment options consist of the Chaperone-Advanced Replacement Therapy or CHART. This is a proven enzyme replacement therapy that the founders use to treat people. CHART is the company’s leading treatment drug. It is used for various patients with unique conditions. This company has been helping the medical community to find viable solutions with their efforts in eliminating specific diseases.
Amicus Therapeutics opened up another facility in San Diego, California in 2008. Their original location is in Cranbury, New Jersey. This organization has also acquired Callidus Biopharma and Scioderm. These acquisitions helped Amicus Therapeutics expand its research and treatment options to combat unusual diseases such as Pompe. Amicus Therapeutics brings in a revenue of $18 million per year and is growing in a positive direction.
The One Planet Business and Professional Excellence Awards were held in January 2017. Troy McQuagge was among the many winners awarded during the awards. Troy, Chief Executive Officer of USHEALTH Group of Companies, won the Gold Award as the C.E.O of the Year.
One Planet Awards are held to honor professionals who have attained excellence in their line of work. All companies and organizations around the world are eligible to submit their nominations for the awards.
In response to his award, Troy commented that his win was a team effort. The award was a representation of the success of USHEALTH in providing quality healthcare services. USHEALTH Group was also honored with a Gold One Planet Awards.
About Troy McQuagge
Troy McQuagge is a dynamic individual with 30 years of experience in the business world. Troy joined USHEALTH Advisors in 2010, and he serves as the President and Chief Executive Officer since then. USHEALTH Advisors is the marketing group of the group. In this position, Troy has managed to develop the strategic plan for the Company.
After achieving much success in the Company, Troy was promoted to the position of President, Chief Executive Officer and a Member of the USHEALTH Group Board of Directors. Over the first three years, Troy has managed to promote and lead the Company to achieve success.
Throughout his career, Troy has received over 20 awards including the CEO World Awards and the Stevie Awards.
For 11 years, Troy served as the President of Agency Marketing Group at the HealthMarket.
Aside from being an excellent leader, Troy has committed his time to giving back to the community. He has volunteered at HopeKids Dallas, Phoneix, Phoneix New Orlean, and Trinity Habitat for Humanity.
Troy holds a Bachelor of Arts in Legal Studies from the University of Central Florida.
About USHEALTH Group
USHEALTH Group of companies has services that protect Americans families in the present and also in the future. Over 50 years, the Company has developed flexible and secure plans. They have innovative health coverage for all the people regardless of their financial status. It is the ability of the team to understand each client’s needs that have given them success. They believe that all customers are unique and not all the services are suitable for everyone. The different products offered by the Company include PremierChoice, Life Protector, Accident and Income Protectors. USHEALTH Group focuses on providing affordable services and learn more about Troy.
USHEALTH Group offers the services through the USHEALTH Advisors. The Advisors have exceptional experience and knowledge. The Advisors must meet the minimum requirements and have the certifications. USHEALTH Advisors have received different awards because of their excellent services and more information click here.
More visit: http://www.ushacareers.com/hope/
James Dondero is the president as well as one of the founders of Highland Capital Management. He has been appointed as a member of the Executive Board for the Southern Methodist University. His new position has the benefit of expanding the already strong commitment made by Highland to SMU. The Cox School located at SMU is a large part of Dallas’s business community. There are approximately 100 members on the board who are mainly non-academics. They meet three times each year with the purpose of strategizing about the business school.
Dondero is the Chairman for CCS Medical, Cornerstone Healthcare, the Nexpoint Residential Trust and Nexbank. In addition he is on the board for MGM Studios and Jernigan Capital.
Highland Capital Management is an investment manager registered with the SEC. When combined with their affiliates their assets total $16 billion. Mark Okada and James Dondero founded Highland in 1993. They have become one of the biggest and most experienced credit managers. Their specializations include special-situation private equity, credit hedge funds, credit strategies, collateralized loan obligations and long-only funds.
Highland also deals in emerging markets, alternative investments and natural resources. They offer endowments, fund of funds and public pension plans as well as several other additional services. They are based in Dallas, Texas although they also have offices in Singapore, New York, Seoul and San Paolo.
James Dondero has more than thirty years of experience in equity and credit markets. He has focused mainly on both distressed and high yield investments. Since Highland was founded in 1993 they have become experts in Collateralized Loans the development of credit solutions for retail and institutional investors.
Before Mr. Dondero began Highland he helped with the creation of a subsidiary of GIC called Protective Life. He has experience as a corporate bond analyst and also as a Portfolio manager when he was with American Express. He started his career in 1984 working for Morgan Guaranty as an analyst. Mr. Dondero was educated at the University of Virginia where he graduated with the highest honors. He had a dual major in finances and accounting.